Medicare Enrolled
Dr. Janice Eakle, M.D.
Hematology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eakle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eakle? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eakle
Dr. Janice Eakle is a hematology in Sarasota, FL, with 20 years in practice. Based on federal Medicare data, Dr. Eakle performed 135,047 Medicare services across 3,537 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eakle received a total of $15,654 from 90 pharmaceutical and/or device companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eakle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 39% volume in FL$ $15,654 industry payments
Medicare Practice Summary
Medicare Utilization ↗135,047
Medicare services
Top 39% in FL for hematology
3,537
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,752 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 64,770 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 18,180 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 17,811 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 9,338 | $36 | $108 |
| Anti-nausea injection (aprepitant) | 9,100 | $1 | $5 |
| Dexamethasone injection (steroid) | 2,528 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,465 | $8 | $29 |
| Blood draw (venipuncture) | 2,150 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,413 | $93 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,380 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,103 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 608 | $0 | $9 |
| Injection of additional new drug or substance into vein | 573 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 521 | $95 | $378 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 373 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 350 | $46 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 348 | $22 | $84 |
| Injection, carboplatin, 50 mg | 270 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 232 | $16 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 213 | $1 | $3 |
| Office visit, established patient (20-29 min) | 163 | $50 | $239 |
| Injection, zoledronic acid, 1 mg | 150 | $6 | $69 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 128 | $54 | $206 |
| Administration of additional new drug or substance into vein, 1 hour or less | 113 | $48 | $178 |
| New patient office visit (45-59 min) | 86 | $120 | $453 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $26 | $89 |
| Red blood count automated, with additional calculations | 80 | $5 | $20 |
| Administration of chemotherapy into vein, each additional hour | 78 | $22 | $79 |
| Infusion into a vein for hydration, each additional hour | 77 | $9 | $42 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 69 | $16 | $59 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 67 | $3 | $11 |
| Automated urinalysis | 59 | $2 | $8 |
| Infusion, normal saline solution , 1000 cc | 55 | $2 | $7 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 34 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 31 | $25 | $156 |
| Drawing of blood for a medical problem | 30 | $68 | $277 |
| Injection of drug or substance into vein | 19 | $27 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.7% high complexity
39.4% medium
4.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,654
Total received (2018-2024)
Avg $2,236/year across 7 years
Top 32% in FL for hematology
90
Companies
913
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,654 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,437
2023$2,493
2022$2,620
2021$1,856
2020$1,794
2019$1,748
2018$1,707
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,258
Celgene Corporation
$965
E.R. Squibb & Sons, L.L.C.
$952
PFIZER INC.
$804
Janssen Biotech, Inc.
$803
Daiichi Sankyo Inc.
$664
Lilly USA, LLC
$585
BeiGene USA, Inc.
$579
Amgen Inc.
$531
Genentech USA, Inc.
$524
Merck Sharp & Dohme Corporation
$518
GENZYME CORPORATION
$485
Incyte Corporation
$475
Merck Sharp & Dohme LLC
$467
Takeda Pharmaceuticals U.S.A., Inc.
$399
Gilead Sciences, Inc.
$396
AstraZeneca Pharmaceuticals LP
$383
Seagen Inc.
$320
ABBVIE INC.
$261
Exelixis Inc.
$196
GlaxoSmithKline, LLC.
$196
ARRAY BIOPHARMA INC
$189
Kite Pharma, Inc.
$175
AbbVie Inc.
$160
Puma Biotechnology, Inc.
$157
Pharmacyclics LLC, An AbbVie Company
$152
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Rigel Pharmaceuticals, Inc.
$147
Eisai Inc.
$139
Bayer HealthCare Pharmaceuticals Inc.
$128
PUMA BIOTECHNOLOGY, INC.
$126
Astellas Pharma US Inc
$119
PharmaEssentia USA Corporation
$111
Regeneron Healthcare Solutions, Inc.
$107
EISAI INC.
$105
Foundation Medicine, Inc.
$78
Stemline Therapeutics Inc.
$77
JAZZ PHARMACEUTICALS INC.
$77
Mirati Therapeutics, Inc.
$73
Karyopharm Therapeutics Inc.
$71
TerSera Therapeutics LLC
$64
EMD Serono, Inc.
$63
Sysmex Inostics Inc
$61
Myovant Sciences Inc.
$59
Janssen Pharmaceuticals, Inc
$57
ADC Therapeutics America, Inc.
$57
Blueprint Medicines Corporation
$57
Helsinn Therapeutics (U.S.), Inc.
$55
Alexion Pharmaceuticals, Inc.
$49
Aveo Pharmaceuticals, Inc.
$48
Dova Pharmaceuticals
$46
Agios Pharmaceuticals, Inc.
$46
Acrotech Biopharma LLC
$44
Pharmacyclics LLC, an AbbVie Company
$44
GE HealthCare
$44
SANOFI-AVENTIS U.S. LLC
$40
Sun Pharmaceutical Industries Inc.
$39
G1 Therapeutics, Inc.
$38
AbbVie, Inc.
$36
Deciphera Pharmaceuticals Inc.
$35
Sumitomo Pharma America, Inc.
$34
SpringWorks Therapeutics, Inc.
$32
GT Medical Technologies, Inc
$29
Taiho Oncology, Inc.
$29
Heron Therapeutics, Inc.
$28
Fennec Pharmaceuticals, Inc.
$27
Dendreon Pharmaceuticals LLC
$27
Bayer Healthcare Pharmaceuticals Inc.
$23
Ipsen Biopharmaceuticals, Inc
$20
Acrotech Biopharma Inc.
$20
Octapharma USA, Inc.
$20
SOBI, INC
$19
TAIHO ONCOLOGY, INC.
$18
MorphoSys, US Inc.
$18
Sobi, Inc
$17
SERVIER PHARMACEUTICALS LLC
$17
Advanced Accelerator Applications
$17
GE HEALTHCARE
$16
Alnylam Pharmaceuticals Inc.
$15
CTI BioPharma Corp.
$15
EKOS Corporation
$15
Partner Therapeutics, Inc.
$15
Pharmacosmos Therapeutics Inc.
$15
EUSA Pharma (US) LLC
$14
INSYS Therapeutics Inc
$14
Lexicon Pharmaceuticals, Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Kyowa Kirin, Inc.
$12
Boston Scientific Corporation
$12
Secura Bio, Inc.
$9
Top 3 companies account for 20.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · EKOSONIC · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · HEMADY · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LARTRUVO · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rituxan Hycela · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · Varithena Administration Pack · Vectibix · Venclexta · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
22
Per 100K population
4.9
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Eakle is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Eakle experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Eakle performed 64,770 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eakle receive payments from pharmaceutical companies?
Yes. Dr. Eakle received a total of $15,654 from 90 companies across 913 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eakle's costs compare to other hematologys in Sarasota?
Dr. Eakle's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eakle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Sarasota
Browse hematologys in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology